LEIDOS BIOMEDICAL RESEARCH INC
Federal contract award, Leidos, $5,418,352
Key CONT_AWD_75N91018F00064_7529_HHSN261201500003I_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 81 days before this system saw it. One version on record.
Cite this row
65e23ee56142e5f32578a8ad2ab74fbd605b17ae36a8e7e44e363a31b726ba5bThe source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.
Versions
| Version | Amount | Change | Occurred | Published | Retrieved | How it arrived | Content hash |
|---|---|---|---|---|---|---|---|
| 1 current | $5,418,352 | first version | September 17, 2018 | June 16, 2026 | 2026-09-05T00:55:21Z | historical sweep | 65e23ee56142 |
Archived copy
https://web.archive.org/web/20261014114923/https://www.usaspending.gov/award/CONT_AWD_75N91018F00064_7529_HHSN261201500003I_7529 captured by this system, October 14, 2026
What the amount is made of
5 recorded actions, so the amount is the award's current total across all of them. 3 of them obligated money. Measured 2026-10-11, when USAspending reported a total obligation of $5,418,352.
| Action date | Modification | Type | Obligated | Description as recorded |
|---|---|---|---|---|
| June 16, 2026 | P00004 | OTHER ADMINISTRATIVE ACTION | no money | ANTIBODY PRODUCTION AND CHARACTERIZATION |
| April 7, 2023 | P00003 | OTHER ADMINISTRATIVE ACTION | no money | ANTIBODY PRODUCTION AND CHARACTERIZATION |
| September 29, 2019 | P00002 | EXERCISE AN OPTION | +$2,164,546 | ANTIBODY PRODUCTION AND CHARACTERIZATION |
| August 14, 2019 | P00001 | EXERCISE AN OPTION | +$2,176,347 | ANTIBODY PRODUCTION AND CHARACTERIZATION |
| September 17, 2018 | base | not on file | +$1,077,459 | ANTIBODY PRODUCTION AND CHARACTERIZATION |
Last refreshed November 4, 2026 at 2:31 PM UTC.